Short acting beta2-agonists for bronchiectasis: Cochrane systematic review
Short acting beta2-agonists for bronchiectasis: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
"Short Acting Beta2-agonists for Bronchiectasis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432781/all/Short_acting_beta2_agonists_for_bronchiectasis:_Cochrane_systematic_review. Accessed 20 August 2019.
Short acting beta2-agonists for bronchiectasis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432781/all/Short_acting_beta2_agonists_for_bronchiectasis:_Cochrane_systematic_review. Accessed August 20, 2019.
Short acting beta2-agonists for bronchiectasis: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/432781/all/Short_acting_beta2_agonists_for_bronchiectasis:_Cochrane_systematic_review
Short Acting Beta2-agonists for Bronchiectasis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2019 August 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432781/all/Short_acting_beta2_agonists_for_bronchiectasis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short acting beta2-agonists for bronchiectasis: Cochrane systematic review
ID - 432781
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432781/all/Short_acting_beta2_agonists_for_bronchiectasis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -